" /> Belizatinib - CISMeF





Preferred Label : Belizatinib;

NCIt synonyms : ALK/TRK Inhibitor TSR-011;

NCIt definition : An orally available inhibitor of both the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the tropomyosin-related kinases (TRK) TRKA, TRKB, and TRKC, with potential antineoplastic activity. Upon oral administration, belizatinib binds to and inhibits both ALK and TRK kinases. The inhibition leads to disruption of ALK- and TRK-mediated signaling and impedes tumor cell growth in ALK/TRK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development; ALK dysregulation and gene rearrangements are associated with a series of tumors. TRK, a family of receptor tyrosine kinases activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth and survival.;

UNII : Z8A6022P3J;

InChIKey : WSTUJEXAPHIEIM-FEGDYQJNSA-N;

CAS number : 1357920-84-3;

Molecule name : TSR 011; TSR-011;

NCI Metathesaurus CUI : CL1382156;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
16/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.